Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;23(3):517-526.
doi: 10.1007/s43630-024-00535-4. Epub 2024 Feb 9.

Oral intake of bucillamine, carvedilol, metformin, or phenformin does not protect against UVR-induced squamous cell carcinomas in hairless mice

Celina Pihl  1   2 , Peter Bjerring  3 , Flemming Andersen  3   4 , Merete Haedersdal  5   6 , Catharina M Lerche  5   7
Affiliations

Oral intake of bucillamine, carvedilol, metformin, or phenformin does not protect against UVR-induced squamous cell carcinomas in hairless mice

Celina Pihl et al. Photochem Photobiol Sci. 2024 Mar.

Abstract

Squamous cell carcinoma represents the second most common type of keratinocyte carcinoma with ultraviolet radiation (UVR) making up the primary risk factor. Oral photoprotection aims to reduce incidence rates through oral intake of photoprotective compounds. Recently, drug repurposing has gained traction as an interesting source of chemoprevention. Because of their reported photoprotective properties, we investigated the potential of bucillamine, carvedilol, metformin, and phenformin as photoprotective compounds following oral intake in UVR-exposed hairless mice. Tumour development was observed in all groups in response to UVR, with only the positive control (Nicotinamide) demonstrating a reduction in tumour incidence (23.8%). No change in tumour development was observed in the four repurposed drug groups compared to the UV control group, whereas nicotinamide significantly reduced carcinogenesis (P = 0.00012). Metformin treatment significantly reduced UVR-induced erythema (P = 0.012), bucillamine and phenformin increased dorsal pigmentation (P = 0.0013, and P = 0.0005), but no other photoprotective effect was observed across the repurposed groups. This study demonstrates that oral supplementation with bucillamine, carvedilol, metformin, or phenformin does not affect UVR-induced carcinogenesis in hairless mice.

Keywords: Drug repurposing; Hairless mice; Photoprotection; Skin cancer; Ultraviolet radiation.

PubMed Disclaimer

References

    1. Ashburn, T. T., & Thor, K. B. (2004). Drug repositioning: Identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery, 3(8), 673–683. https://doi.org/10.1038/nrd1468 - DOI - PubMed
    1. Nosengo, N. (2016). Can you teach old drugs new tricks? Nature, 534(7607), 7607. https://doi.org/10.1038/534314a - DOI
    1. Smith, S. B., Dampier, W., Tozeren, A., Brown, J. R., & Magid-Slav, M. (2012). Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis. PLoS ONE, 7(3), e33174. https://doi.org/10.1371/journal.pone.0033174 - DOI - PubMed - PMC
    1. Kim, Y., & He, Y.-Y. (2014). Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation. Genes & Diseases, 1(2), 188–198. https://doi.org/10.1016/j.gendis.2014.08.005 - DOI
    1. Birch-Johansen, F., Jensen, A., Mortensen, L., Olesen, A. B., & Kjær, S. K. (2010). Trends in the incidence of nonmelanoma skin cancer in Denmark 1978–2007: Rapid incidence increase among young Danish women. International Journal of Cancer, 127(9), 2190–2198. https://doi.org/10.1002/ijc.25411 - DOI - PubMed

LinkOut - more resources